Very underrated company! |
This reacts very positively to decent buys, nice tight stock being held here. |
Great opportunity to purchase NOW 🚀🚀🚀 |
I agree and whilst the raise at open looked justified I was gobsmacked at closing price. Debt did increase yoy and I would like to be confident of sales momentum and market opportunity, No presentations from Company as far as I can see. |
Hey this ought to help GDR! |
Probably a combination of relief at covenant compliance (no further fund raise), sales momentum in most valuable part of group (OEM) and medium term prospect of an offer from Mennen, who recently increased to c. 10%. The register is quite concentrated. BGF (21%), Former directors (15%) and one of Liontrust (4.7%) or Octopus (4.2%)would get Mennen over 50%. I suspect the business needs to improve considerably to get a realistic bid, but it appears to be on a better trajectory with a credible team. I suspect the institutions would take 40p-ish and move on. |
Up 100%. Congratulations to all holders! I was looking at these a few days ago. Kind of wish I had bought. :-( |
I guess it's a relief rally that things weren't worse. Bit strange given it was a profit warning with Panmures downgrading FY25 PBT by 14% and FY26 by 46%. At 23p, the fwd PE is 40 for FY26 which seems quite rich at the moment IMHO. |
No posts here, amazing ? |
An encouraging update today. |
COO obviously didn't get the job, new appointee is a mid 50s Greek guy with requisite US experience. Not sure after looking at LinkedIn, need to judge a presentation. My dream ticket would have been Roy retaining exec role to mentor a less experienced but sales oriented person. |
Just 2804 shares were traded today and IHC business is worth 4.55% less than it was yesterday.
The nonsense that is AIM market and low liquidity / big spreads! |
Not quite sure why resignation of COO should result in a share price decline as it looks like a clear out of old guard by CEO to my eyes. |
The decline in sales of t incubators is quite alarming and inventory now much too high. Having listened to presentation the emphasis seemed to be on better execution and appointment of CEO. They seemed confident they had stabilised matters but it looks a long road back to growth. |
VAST RECOURSES to re coupe some dosh ;) |
Crikey poor shareholdersUtter bargepole this - 10p open? |
gnnmartin
your SIPP account won't let you buy.
May I suggest that you (& everyone suffering from similar problems at their broker) move your account to a different broker (after first checking that the new broker would allow it).
The famously incompetent & useless British regulator is forcing brokers to do this type of interference with clients' execution accounts when an execution only account should by definition be left to the client to trade solely as he/she decides.
The UK, at times the stupidity beggars belief. Other examples are the Metropolitan police, the Post Office management (their illegal acts in intentionally prosecuting people they knew were innocent !!, ffs ! & the Govt ministers supervising that management), Grenfell tower (use of flammable building materials was allowed to happen). |
$4.3m delayed contract finally signed - ventillators etc to be deliver in H2.
Good news. |
Congratulations to management for awarding themselves nil cost options as a reward for decimating shareholder value. |
Worth catching up with ST article in IC. Lots of work on the sales side to do here but new management deserves a chance |
My SIPP won't let me subscribe. It's a "compliance" restriction, whatever that means. :-( |
I notice that they don't seem to be doing investors presentation this time as previously regulars on investors meet.There seems no sales momentum and I would like to understand this aspect better before investing. |
 Pretty grim, but at least signs of Roy Davies getting a grip and injecting some reality. Suspect mandate from major shareholders is to get it sorted and sold in 2 years. His track record in that regard is pretty good.
RD, new FD and team were always going to "kitchen sink" it this time. Cash and covenant breaches made a fund raise likely to access liquidity. Suspect new FD can get more cash out of working capital (e.g. inventory).
Positive focus on core products. Expensive vanity projects (Wave and cooling) have been shot with £4m capitalised R&D written off. Should now be much less capitalisation, which means earnings should better reflect cash generation.
US always going to be hard. The market favours manual rather than algorithmic controls (partly due to liability concerns).
Revenue bridge looks optimistic. More likely to be mid 30s again unless ME does actually land, but suspect more cost will come out.
Overall, pretty grim, but I will probably give RD and underlying tech the benefit of the doubt and subscribe. |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
